Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Safety, side effects, and the boxed warning Willow's medications and PlexusDx protocols both prescribe in the GLP-1 receptor agonist class (semaglutide) or the GIP/GLP-1 dual-agonist class (tirzepatide)
A study published in JAMA in January 2025 which looked at more than 125,000 overweight or obese people found that nearly 47% of those with type 2 diabetes and 65% of those without diabetes stopped taking their prescribed GLP-1s within a year of starting them
Some people ask about it for stomach and digestive concerns
Keep away from heat, freeze and humidity
US$ 20.65
US$ 27.69
US$ 28.43
:max_bytes(150000):strip_icc()/VWH-GettyImages-2276706586.jpg-4e49ad1f948143ed99767b89bf0289d7.jpg)
US$ 20.28
